Effectiveness Comparison of Third-Generation EGFR-TKI As Initial and Sequential Therapy in Adjuvant Treatment for EGFR Mutation-Sensitive Stage IIIA Non-Small Cell Lung Cancer after Surgery
HELIYON（2023）
关键词
EGFR mutation,Lung adenocarcinoma,Stage IIIA,Osimertinib,First-generation TKIs,Treatment sequential,Survival
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要